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Abstract
Introduction There is little experience with the nationwide
implementation of an evidence-based pediatric guideline on
first-choice fluid for resuscitation in hypovolemia.
Methods We investigated fluid prescribing behavior at (1)
guideline development, (2) after guideline development,
and (3) after active implementation and identified potential
barriers and facilitators for guideline implementation. In
order to minimize costs and to optimize implementation
effect, we continuously developed and adjusted implemen-
tation strategies according to identified barriers. Implemen-
tation success was evaluated using questionnaires,
pharmaceutical data, and data from medical records.
Discussion The most remarkable change occurred after
guideline development and dissemination: Normal saline
use by neonatologists increased from 22–89% to 100% and
by pediatric intensivists from 43–71% to 88–100%, and
synthetic colloid use by pediatric intensivists declined from
29–43% to 0–13% with a reduction in albumin use by
neonatologists from 11–44% to 0%. After active guideline
implementation, most of specialist’s management behavior
was according to the guideline.
Conclusion Stakeholders involved in the developmental
process are of great importance in disseminating recom-
mendations before active implementation. Therefore, to
successfully implement guidelines and reduce costs of
active implementation, any guideline development should
consider implementation right from the beginning. Imple-
mentation strategies should target identified barriers and
will therefore always be guideline specific.
Keywords Implementation.Pediatrics.Guideline.Barriers
andfacilitators.Quality-of-careindicators
Introduction
Clinical practice guidelines can facilitate translation of
research into clinical practice and are seen as powerful
tools to achieve effective care, reduce variability in daily
practice, and may reduce costs [14]. However, many
guidelines are not used in daily practice unless they are
actively implemented pursuing consolidation of behavior
change [12]. So far, there is little experience with the
implementation of pediatric evidence-based guidelines,
and the specific strategies favoring success are not well
known.
In 2000, a Dutch multidisciplinary national committee
developed an evidence-based guideline on the first-choice
fluid for resuscitation of hypovolemic shock due to
dehydration, sepsis, trauma, and hemorrhage in critically
ill neonates and children up to 18 years. In 2004, it was
updated. The guideline recommends normal saline as the
first-choice treatment for all forms of hypovolemic shock
[4]. In 2004, we started an implementation project with two
objectives. Our first goal was to successfully implement the
guideline’s recommendations. Our second aim was to learn
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pediatric guidelines. In this paper, we describe (1) pre- and
postimplementation questionnaire surveys to investigate
first-choice fluid use in various pediatric departments, (2)
implementation barriers and facilitators encountered, (3) the
tailored implementation strategies that were used, (4)
quality-of-care indicators that we used to evaluate the
implementation success, and (5) lessons learnt for the
implementation of future pediatric guidelines.
Materials and methods
Questionnaires, barriers, and facilitators
and implementation strategies
Preguideline questionnaire survey
Questionnaire A was developed (2000) to investigate
pediatric practice before guideline development and to
identify barriers and facilitators for guideline implementa-
tion. Questions concerned the first-choice plasma volume
expanders in various forms of hypovolemic shock. It was
sent to all heads of Dutch pediatric (PICU) and neonatal
(NICU) intensive care units; all of them were also involved
in the guideline development process (Fig. 1).
Postguideline questionnaire survey
Two questionnaires were developed: questionnaire B for
guideline development committee members and question-
naire C for all specialists not involved in the guideline
development process but involved in treatment of hypo-
volemic children. Questionnaire B evaluated if the guide-
line had been implemented on the departments of the
committee members. Implementation was defined as “the
methods used to promote the uptake of the guideline on
pediatric departments with the purpose of obtaining a
structural place in medical care”. Identified barriers and
facilitators were used to develop effective implementation
strategies (Table 1). Questionnaire C evaluated fluid
resuscitation practice in 151 randomly chosen specialists
from all academic and all general hospitals (in general
hospitals, the head of the department; in academic centers,
the specialist on call): one pediatrician from all general
hospitals, one pediatric anesthesiologist from all academic
and burn centers and some general hospitals, one pediatric
surgeon from all academic and burn centers, and one
neonatologist and pediatric intensivist from all academic
centers. Implementation barriers and facilitators were
identified in order to develop effective implementation
strategies for each different specialism. Questionnaire C
contained ten questions exploring awareness and use of the
existing national guideline, first-choice plasma volume
expanders, and frequency of use.
Implementation strategies
As the frequency of fluid resuscitation is the highest in
academic centers, extra attention was given as an imple-
mentation strategy. One staff member (the specialist on call,
not the committee member) of each of the academic
pediatric specialist units was visited by the guideline
development and implementation group (MT). During this
visit, questionnaire C was filled out and barriers and
facilitators were identified (Table 1). To specialists working
in general hospitals (n=121), the questionnaires were sent
by postal mail to the head of the department with a stamped
addressed return envelope included. An accompanying
letter explained the rationale for the survey and offered an
incentive, proposed as “a valuable document for your
hospital’s library”. After 6 weeks, nonresponders were
called.
In 2005, all involved clinicians received a printed
version of the guideline. In addition, subdivision chairs
of the Dutch Association of Pediatric Surgery, Pediatric
Anesthesiology, Neonatology, Pediatric Intensive Care,
and General Hospital Pediatric Practices received it and
were asked to inform their members about the recom-
mendations. Every visitor of the yearly congress of
Dutch pediatricians received a pocket-size plasticized
card with the guideline recommendations (n=1,000) and
were asked to answer three questions about the guideline
at our “implementation stand”. In return, they received an
incentive. During 2005, every 2 months, a newsletter
about this implementation project was published in the
journal of the Dutch Pediatric Society. Guideline’s
recommendations were also published in the Dutch
Journal of Pediatrics [26]. From 2001 on, all consecutive
Dutch first-year pediatric residents (n=720) were taught
interactively about the guideline by the chair of the
guideline development committee (NB).
Evaluation of implementation success
The following quality-of-care indicators were developed:
percentage of specialists aware of the guideline, percentage
of specialists reportedly following the guideline, and
change (% liters) of annual use of volume expanders (i.e.,
albumin, synthetic colloids, and crystalloids). Quality-of-
care indicators were measured using questionnaires, hospi-
tal pharmaceutical data, and data from medical records.
Successful implementation was defined as a 10% change in
quality-of-care indicators after active implementation.
Details on how these changes were measured are given
below.
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After analyzing the results of all questionnaires (2006), we
defined two target groups to evaluate the success of active
implementation: (1) general hospital pediatric departments
that had reported not to always follow the recommendations
(27 out of all 95, 28%) and (2) all academic departments of
pediatric anesthesiology because of their lowest use of
crystalloids and because their frequency of fluid use is
relatively high. One member of the guideline development
and implementation group (MT) called these practices (n=
35) and asked to speak to the pediatrician/anesthesiologist
on call, being not the one already visited in 2004. Questions
concerned (1) awareness of the guideline, (2) whether the
guideline’s recommendations were always followed, and
(3) first-choice volume expanders. The actual question-
naires can be provided upon request from the authors.
Pharmaceutical data
We tried to collect data on the annual volume in liters of
different plasma solutions used per department for the
indication of hypovolemia in children before guideline
development onset in 2000, in 2004, and after active
implementation in 2006. Given that the highest amount of
intravenous fluids was prescribed in academic hospital
centers, data from all academic pharmacies (n=8) were
collected (Fig. 2).
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Initial plasma volume expander used was extracted from
the medical records of 120 consecutive patients who were
treated for hypovolemia in January and February 2006 on
three academic neonatal and three pediatric intensive care
units (n=6): (1) one with the highest amount of albumin
use, (2) one with the highest amount of nonhuman colloids
use, and (3) one with moderate use of all plasma volume
expanders compared with other academic centers. With a
number of 20 medical records per academic hospital unit
concerning 20 hypovolemic children in all of whom saline
0.9% is prescribed as first-line treatment, one can conclude
with a 95% confidence interval of 84–100% that for all
hypovolemic children on that department, normal saline is
used as first-line treatment. Figure 3 shows the chain of
events on a time scale.
Data analysis
Statistical analysis included descriptive statistics and
frequency analysis. All analyses were performed using
SPSS 12.0 (SPSS, Chicago, IL, USA). Microsoft Excel was
used for analyzing pharmaceutical data.
Results
Questionnaire surveys
Response rate
Response rates to questionnaires A and B and C were
95% (17 of 18), 77% (20 of 26), and 99% (150 of 151),
respectively. In case of missing answers, respondents
Table 1 Reported implementation barriers and facilitators and implementation strategies
Barriers
Uncertain applicability of evidence from adults to children
Fear of inducing hypernatremia in neonates when using normal saline
Existence of a local protocol
Ongoing recommendation to use albumin or synthetic colloids by international “opinion leaders”
“Old habits and routines” that seem to work well
Unclear accessibility of the new guideline, lack of detailed knowledge about guideline’s recommendations, reported “unclear recommendations”,
and “extensive guideline”
Facilitators
“Evidence-based” guideline, relevant to practice, with clear recommendations
Motivated members of multidisciplinary committee
Digital free accessibility of the guideline
Strategies
At guideline development onset
Personal interviews with academic specialists aimed at identification of potential barriers and facilitators for implementation
Formation of multidisciplinary guideline development committee consisting of all stakeholders’ representatives
During guideline development
Use of evidence-based guideline development process
Potential barriers to implementation addressed in guideline
Involvement of all stakeholders in formulating the final guideline recommendations
Local implementation by stakeholders on their departments and in regional hospitals
After guideline development
Endorsement of guideline by the Dutch Association of Pediatrics
Educational visits of academic specialists
Information stand at Dutch annual pediatric meeting; checking participants’ recommendation knowledge offering a reward (plastic duck filled
with bath salts)
Proposed incentive: printed copy of full-text guideline for those who fill out questionnaires
Dissemination of the guideline’s recommendation as a pocket-size plasticized card
Digital free access to the full text guideline
Publication of the guideline’s recommendation in the newsletter of the Dutch Association of Pediatrics and Dutch Journal of Pediatrics
Interactive lessons about guideline recommendations for all Dutch pediatric residents
752 Eur J Pediatr (2010) 169:749–758were approached. Finally, all questionnaires were fully
completed.
Barriers to and facilitators for guideline implementation
and implementation strategies used
Table 1 shows barriers and facilitators to implementation
reported during the whole process of guideline develop-
ment and implementation and all implementation strategies
used.
First-choice fluid therapy before and after guideline
development
Figure 2a–d shows reported use of first-choice volume
therapy for all forms of hypovolemic shock in different
clinical settings before (in 2000) and after guideline
development (in 2004) and after active implementation (in
2006). Active implementation started in 2004. Only a
minority used other crystalloids instead of normal saline.
Although normal saline was recommended in the guideline,
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Fig. 2 a Proportion first-choice
fluid in dehydration before
(2000), after guideline develop-
ment (2004), and after active
implementation (2006) accord-
ing to specialty. b Proportion
first-choice fluid in sepsis before
(2000), after guideline develop-
ment (2004), and after active
implementation (2006) accord-
ing to specialty. c Proportion
first-choice fluid in trauma be-
fore (2000), after guideline de-
velopment (2004), and after
active implementation (2006)
according to specialty. d Pro-
portion first-choice fluid in
hemorrhage before guideline
development (2000), after
guideline development (2004),
and after active implementation
(2006) according to specialty.
Data were not obtained for all
years for each different specialty
(see “Materials and methods”).
Academic specialists: NICU—
n=10 in 2000, n=8 in 2004,
neonatologists do not encounter
trauma as a cause for hypovole-
mia in neonates; PICU—n=7 in
2000, n=8 in 2004; pediatric
anesthesiology departments—
n=8 in 2004 and 2006; pediatric
surgery departments—n=6 in
2004. General hospital pediatri-
cians—n=95 in 2004
Eur J Pediatr (2010) 169:749–758 753for ease of reading and interpretation, we report “total
crystalloid use”.
Beforeguidelinedevelopment,first-choicefluidtherapyon
the NICUs for different forms of shock was crystalloid in 22–
89%, albumin in 11–44%, and synthetic colloid in 0–11%.
After guideline development, reported use was 100%, 0%,
and0%,respectively.Beforeguidelinedevelopment,itwason
the PICU’sc r y s t a l l o i di n4 3 –71%, albumin in 0–14%, and
synthetic colloid in 29–43%. After guideline development, it
was 88–100%, 0%, and 0–13%, respectively. After guideline
development,butbeforeactiveimplementation,reportedfirst-
choice fluid therapy in general hospital pediatric departments
wasacrystalloidin84–100%,albuminin0–1%,andsynthetic
colloidin0–2%;inacademicpediatricsurgicaldepartments,it
was 33–100%, 0–17%, and 0–17%, respectively, and in
academic pediatric anesthesiology departments, it was 50–
88%, 0%, and 13–38%, respectively. This last group was
evaluated after active implementation: 75–100% now
reported crystalloids as first choice, albumin 0%, and
synthetic colloids 0–25%. Of all participants, 68% reported
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754 Eur J Pediatr (2010) 169:749–758never to use colloids for volume therapy in hypovolemic
shock and 32 % sporadically, i.e., 90% of these 32% less than
once a month.
Local implementation and barriers and facilitators met
by members of the multidisciplinary guideline development
committee
Up to 95% of respondents of the guideline development
committee reportedly already implemented the guideline
after 2001. Only 15% (three of 20) reported barriers during
their implementation consisting of “a too extensive guide-
line text” and “routines or old habits”.
Frequency of prescribing fluids for volume therapy
On average, academic pediatric specialists prescribe fluid
therapy daily or several times a week. General hospital
pediatricians prescribe fluid therapy monthly to once in
every 3 months. General pediatric anesthesiologists pre-
scribe initial fluid therapy once in 3 months.
Awareness of guideline by pediatric specialists not involved
in the guideline development
Before active implementation, 52% (78 of 150) of all
practitioners, mainly general hospital pediatricians 66% (63
of 95), were aware of the guideline.
Adherence to the guideline
Of academic specialists, 64% (nine of 14) always followed
the recommendations, 29% (four of 14) inconsistently, and
7% (one of 14) never (“own protocol”). Main reason given
for inconsistent use was “unclear recommendations” in
50% (two of four) and “insufficient knowledge of these
recommendations” in 50% (two of four). Many specialists
complained that the guideline was too long and too
extensive. Reporting to questionnaire C, 57% (36 of 63)
of general pediatricians who were aware of the guideline
claimed to “always follow the recommendations” and 43%
(27 of 63) “inconsistently”. Lack of detailed knowledge
about the recommendations was mentioned by 57% as main
reason for inconsistent use.
Evaluation using indicators
Reported behavior
Before active implementation, only 13% (one of eight) of
academic pediatric anesthesiologist were familiar with the
guideline compared to 50% (four of eight) after active
implementation. Before active implementation, 43% (27 of
63) of general hospital pediatricians aware of the guideline
did not always follow the guideline. After active imple-
mentation, 89% (24 of 27) claimed to “always” follow the
recommendations. Eleven percent (three of 27) was not
Active implementation
Pharmaceutical data
C
Teaching residents
Guideline development
jan dec jan jan jan jan mar dec
2000 2000 2001 2002 2003 2004 2005 2006 2006 2006
A:  Questionnaire A
B:  Questionnaire B 
C:  Questionnaire C
O:  Other implementation strategies (see also table 2):
- printed version guideline
- information stand at annual pediatric meeting
- guideline in newsletter of the Dutch Association of Pediatrics and Dutch Journal of Pediatrics
Z: - Phonecall to target groups
- Medical records
A
B
C
O Z
Fig. 3 Chain of events on a
time scale
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already used normal saline as first-choice treatment.
Pharmaceutical data
Response rate of academic pharmacists was 100%. All
pharmacists could only provide data on total fluid use (in
liters) per year for 2004 and 2006. No electronic data were
available for 2000. They were unable to specify data: (1)
per indication, (2) on the number of children receiving fluid
therapy, and (3) for each department separately. Therefore,
we dismissed all results.
Medical records
A total of 120 medical records were included. This showed
that 109 of 120 (92%) of hypovolemic children received
normal saline and that five out of six departments used
normal saline in all 20 consecutive cases for initial
treatment. This was after active implementation and in
keeping with the answers given in the questionnaire.
Discussion
We observed a remarkable change in prescribing practice
by Dutch physicians. Usually, changes in care after
guideline development and implementation are not that
overwhelming, with a median 10% improvement of care
[12, 15]. Some important lessons can be learnt about
pediatric guideline development and implementation in
general. We will discuss the state of evidence for the
various strategies, strengths, and weaknesses of implemen-
tation study designs in general and give recommendations
for future guideline implementation.
Evidence and marketing in fluid prescribing behavior
Several surveys have shown that, despite publication of
systematic reviews [1, 2, 7], this evidence has not changed
clinical practice and most physicians still use colloid
products [24, 25]. One survey among pediatric anesthesi-
ologists showed that albumin continues to be the most
frequently used volume expander in neonates, whereas
alternative colloids are used in older children [25]. This is
quite surprising since pediatric clinical research with
hetastarch and gelatins is almost nonexistent. Several
authors have shown that physicians may change their
prescribing practice as a result of contact with drug
retailers, irrespective of scientific evidence [8, 19, 22].
Marketing strategies by the industry involves regular visits
of stakeholders and identifying barriers. We copied this
approach in our implementation study.
Guideline development and implementation
A guideline should be developed according to evidence-
based principles which facilitate the acceptance and
effective use in the target group [6]. The following
guideline characteristics have been shown to contribute to
their use in practice: inclusion of specific recommenda-
tions, sufficient supporting evidence, a clear structure, an
attractive layout, and short summaries [16]. Guideline
endorsement by a physician’s own specialty organization
is associated with improved physician’sc o n f i d e n c ei na
guideline [17, 23]. Surveys of pediatrician’s attitudes
about guidelines report barriers to adherence such as lack
of awareness, lack of agreement with specific recommen-
dations, or lack of agreement with the concept of guide-
lines in general [9]. Identification of these barriers can
foster opportunities to improve physician adherence to a
guideline. Physician participation in guideline develop-
ment has been shown to be useful in addressing barriers
owing to lack of agreement [18]. Recent graduates are
more likely to find guidelines helpful and reported change
of behavior more often than in seasoned practitioners [9].
Our guideline was developed using evidence-based guide-
line development principles [4, 20]. All stakeholders were
involved in the entire process of guideline development
and implementation.
Fluid prescribing behavior after guideline development
After guideline development and before active implemen-
tation, all neonatologists used normal saline and 88% of
pediatric intensivists. Albumin use had declined to zero.
Our survey before active guideline implementation showed
that most of the pediatric specialist’s management behavior
was already in keeping with the guideline’s recommenda-
tions. We presume that stakeholders (i.e., key clinician
leaders in the field of hypovolemia) who were involved in
the developmental process were disseminating the recom-
mendations in their region as 95% of the guideline
development committee members reportedly had imple-
mented the guideline in their own departments (see “Local
implementation and barriers and facilitators met by members
of the multidisciplinary guideline development committee” in
“Results” section)
Implementation strategies and study design
Several systematic reviews have showed that there is no
“magic bullet” for implementation success [3, 12, 21].
Interventions that consistently have shown effectiveness
include interactive educational meetings, educational out-
reach visits, reminders, and multifaceted interventions.
Interventions with variable effectiveness include audit and
756 Eur J Pediatr (2010) 169:749–758feedback, use of local opinion leaders, local consensus
processes, and patient-mediated interventions. Interventions
with little or no effect are didactic educational meetings and
educational materials [3, 11, 12].
There is a strong call for multiple arm cluster
randomized controlled trials to investigate the (cost-)
effectiveness of various different implementation strate-
gies [10, 13]. An important advantage of this design is the
high internal validity, meaning that a causal relation
between implementation strategies and observed change
in practice can be demonstrated. Disadvantages are the
fact that they are expensive, time-consuming, and,
generally, will have low external validity and applicability
outside the context of the guideline at hand. First of all,
the success of implementation has been shown to be very
much dependent on the guideline development process.
Second, the effect of different implementation strategies
like outreach visits will all highly depend on the
commitment and skills of the persons executing these
strategies. Their effectiveness and importance cannot be
overstated, but, unfortunately, cannot be quantitated as
typical aspects of an intervention. All these issues will be
guideline specific and we therefore believe that the results
of randomized implementation trials will have a limited
applicability to future guidelines in other specialties and
other countries. An alternative design is “interrupted time
series”. This design is useful to detect whether the
intervention (i.e., implementation strategy) has had an
effect that is greater than what would be expected by the
underlying secular trend. Data are collected at multiple
time points before and after the intervention. A disadvan-
tage of this design is the fact that it is necessary to collect
sufficient data points, which is time- and resource-
consuming, and the fact that analysis of data and its
interpretation is usually complicated [10].
We decided it would be most efficient to continuously
develop and adjust implementation strategies according to
identified barriers in this particular case.
Evaluation of implementation success by indicators
No patient-oriented outcomes could be used because
evidence showed no difference between treatments. In our
case, the percentage change in amount of volume expanders
used was the main indicator. According to the question-
naires, active implementation was successful as well. As
self-reported measures potentially reveal an idealized
version of actual behavior, we developed two more
objective indicators: pharmaceutical data and medical
records.
Pharmaceutical data appeared to be invalid (see
“Results”). Data from medical records showed that 92%
of hypovolemic children actually received normal saline.
This was after active implementation of the guideline and in
keeping with the answers given in the questionnaire. We
therefore believe we can rely on the answers obtained from
the questionnaires.
Limitations
Our study has several limitations. A disadvantage of our
uncontrolled design is the fact that a causal relationship
between implementation strategies and observed prescrib-
ing changes cannot be considered proven, and therefore, the
results should be interpreted with caution. Changes in
prescribing behavior coul da l s ob ear e s u l to ft h e
publication of Cochrane reviews and the Saline versus
Albumin Fluid Evaluation (SAFE) trial. In our survey, all
participants were asked to motivate their decision on first-
choice plasma volume expanders in different types of
hypovolemic shock. Yet, none of them mentioned the
SAFE trial. Therefore, guideline development and imple-
mentation were important factors in the change of fluid
prescribing behavior. Another possible limitation is the fact
that we evaluated postactive implementation success in a
limited group of specialists. Because most of physician’s
prescribing behavior was already in keeping with the
guideline, it was not cost-effective to extensively evaluate
fluid prescribing behavior in all specialists after active
implementation. Yet, we obtained data from medical
records that showed that indeed 92% of children in
university hospitals received normal saline.
A clear limitation may be the use of a self-report
measure (questionnaires) in this study. We tried to minimize
this bias assuring physicians anonymity. Furthermore, data
collection differed between academic centers and general
hospitals (personal interview vs. mail survey). Possible bias
toward perceived acceptable responses in personal inter-
views is therefore possible. However, the results obtained
from the medical records were in keeping with the results
from the questionnaires.
Finally, we demonstrate early successful implementation,
which does not necessarily ensure longer-term effectiveness
[5]. Therefore, monitoring by indicators at regular intervals
remains necessary.
Conclusions
Stakeholders are of great importance in the process of
guideline formulation and implementation. Furthermore, we
believe that specifically targeting implementation strategies
to identified barriers has played an important role in our
observed change in practice. As these barriers will always
be guideline specific, every implementation project should
be tailor made.
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